Stephen G. Carter

Keine laufenden Positionen mehr

70 Jahre

Health Technology

Consumer Non-Durables

Profil

Stephen G.
Carter worked as the Director, Chief Scientific Officer & VP at Vaso Active Pharmaceuticals, Inc. from 2009 to 2012.
He also worked as the Chief Scientific Officer at Biochemics, Inc.

Ehemalige bekannte Positionen von Stephen G. Carter

Unternehmen	Position	Ende
Vaso Active Pharmaceuticals, Inc. Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish.	Technik-/Wissenschafts-/F&E-Leiter	06.11.2012
Biochemics, Inc. Biochemics, Inc. Household/Personal CareConsumer Non-Durables Biochemics, Inc. engages in the provision of pharmaceutical services. The company is headquartered in Danvers, MA.	Technik-/Wissenschafts-/F&E-Leiter	-

Sehen Sie sich die Erfahrung von Stephen G. Carter im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Stephen G. Carter im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Vaso Active Pharmaceuticals, Inc. Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish.	Health Technology
Biochemics, Inc. Biochemics, Inc. Household/Personal CareConsumer Non-Durables Biochemics, Inc. engages in the provision of pharmaceutical services. The company is headquartered in Danvers, MA.	Consumer Non-Durables